NCT04082767View on ClinicalTrials.gov

Sedation Efficacy of Dexmedetomidine Versus Midazolam in Critically Ill Ventilated Children

PHASE3RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 8, 2021

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Mechanically Ventilated, Critically Ill Children
Interventions
DRUG

Precedex

Precedex, dexmedetomidine hydrochloride, IV, 4mcg/mL, infusion duration determined by the clinical care team

DRUG

Midazolam

Midazolam, IV, 5mg/mL (for patients more than 10kg), 1mg/mL (for patients 2-10kg), infusion duration determined by the clinical care team

Trial Locations (1)

N6A 5W9

RECRUITING

Children's Hospital - London Health Sciences Centre, London

All Listed Sponsors
lead

Douglas Fraser

OTHER